We are live on ! Find out more
FIS

FCPM III Services Portfolio holdings

AUM $722M
1-Year Est. Return 73.61%
This Fund
S&P 500
This Quarter Est. Return
+108.14%
1 Year Est. Return
+73.61%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$707M
AUM Growth
+$368M
Cap. Flow
+$35.7M
Cap. Flow %
5.05%
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
1
Reduced
2
Closed
–

Top Buys

Rank Stock Value
1
DYN icon
Dyne Therapeutics
DYN
+$38.8M

Top Sells

Rank Stock Value
1
ENGNW icon
enGene Therapeutics Warrants
ENGNW
+$3.05M
2
REPL icon
Replimune Group
REPL
+$410

Sector Composition

Rank Sector Weight
1 Healthcare 97.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NAMS icon
1
NewAmsterdam Pharma
NAMS
$3.47B
$280M 39.56%
11,831,461
– –
DYN icon
2
Dyne Therapeutics
DYN
$3.88B
$223M 31.49%
7,845,364
+1,714,285
+28% +$38.8M
ENGN icon
3
enGene Therapeutics
ENGN
$125M
$147M 20.79%
8,677,951
– –
REPL icon
4
Replimune Group
REPL
$882M
$39.8M 5.62%
4,866,449
-50
-0% -$410
ENGNW icon
5
enGene Therapeutics Warrants
ENGNW
$3.53M
$15M 2.12%
2,878,148
-1,000,000
-26% -$3.05M
ACHL
6
DELISTED
Achilles Therapeutics
ACHL
$2.99M 0.42%
2,390,050
– –

Similar funds

ZDA
Zweig-DiMenna Associates New York $722M AUM 97.69% 1-Year Est. Return
ZAM
Zevin Asset Management Boston, Massachusetts $723M AUM 15.62% 1-Year Est. Return
AF
Apollon Financial Mount Pleasant, South Carolina $723M AUM 24.23% 1-Year Est. Return
UW
Unique Wealth Clearwater, Florida $723M AUM 16.35% 1-Year Est. Return
PPW
Pasadena Private Wealth Pasadena, California $723M AUM 18.72% 1-Year Est. Return
VCM
Vivaldi Capital Management Chicago, Illinois $723M AUM 30.89% 1-Year Est. Return
FFM
FengHe Fund Management Singapore $724M AUM 196.18% 1-Year Est. Return
WLIM
White Lighthouse Investment Management Bedford, Massachusetts $721M AUM 16.12% 1-Year Est. Return

FCPM III Services's Q1 2024 Portfolio in Review

As of Q1 2024, FCPM III Services held 6 positions worth $707M, up 108% from $339M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

FCPM III Services deployed $35.7M of net new capital in Q1 2024, adding to 1 existing holding.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, down from 99% a quarter earlier.

On the sell side, the largest reduction was enGene Therapeutics Warrants, an estimated $3.05M trimmed.

  • FCPM III Services added most to Dyne Therapeutics in Q1 2024, an estimated $38.8M increase.
  • FCPM III Services's biggest Q1 2024 reduction was enGene Therapeutics Warrants, cutting an estimated $3.05M.
  • FCPM III Services's ten largest holdings make up 100% of its $707M portfolio in Q1 2024.
  • FCPM III Services opened 0 new positions and closed 0 in Q1 2024.
  • FCPM III Services's portfolio value rose 108% quarter-over-quarter to $707M.

Based on FCPM III Services's 13F filing for Q1 2024, filed 3 May 2024.